what is the most performance mid cap stock between january 2012 and march 2012

TG Therapeutics (TGTX) had the highest return between January 1, 2012 and March 31, 2012 by a mid-cap US stock, returning 233.3%.

ASSET DATE % RETURN
TG Therapeutics (TGTX)
1/1/2012 - 3/31/2012
233.33%
Patrick Industries (PATK)
1/1/2012 - 3/31/2012
194.2%
Quantum Computing  (QUBT)
1/1/2012 - 3/31/2012
177.78%
Caesars Entertainment (CZR)
1/1/2012 - 3/31/2012
161.17%
IES (IESC)
1/1/2012 - 3/31/2012
110.96%
Sarepta Therapeutics (SRPT)
1/1/2012 - 3/31/2012
103.97%
ACADIA Pharmaceuticals (ACAD)
1/1/2012 - 3/31/2012
95.45%
BioCryst Pharmaceuticals (BCRX)
1/1/2012 - 3/31/2012
90.91%
Radian (RDN)
1/1/2012 - 3/31/2012
83.66%
Frontline (FRO)
1/1/2012 - 3/31/2012
73.2%
Civitas Resources (CIVI)
1/1/2012 - 3/31/2012
72.86%
Skyline (SKY)
1/1/2012 - 3/31/2012
71.53%
Capri (CPRI)
1/1/2012 - 3/31/2012
70.97%
Repligen (RGEN)
1/1/2012 - 3/31/2012
70.52%
Marriot Vacations Worldwide (VAC)
1/1/2012 - 3/31/2012
63.38%
Whirlpool (WHR)
1/1/2012 - 3/31/2012
60.05%
Terex (TEX)
1/1/2012 - 3/31/2012
58.12%
Westlake Chemical (WLK)
1/1/2012 - 3/31/2012
57.83%
Sandstorm Gold Ltd N (SAND)
1/1/2012 - 3/31/2012
55.56%
Arrowhead Pharmaceuticals (ARWR)
1/1/2012 - 3/31/2012
52.27%
ASGN (ASGN)
1/1/2012 - 3/31/2012
51.52%
Prestige Brand (PBH)
1/1/2012 - 3/31/2012
50.69%
EPAM Systems (EPAM)
1/1/2012 - 3/31/2012
49.24%
IPG Photonics (IPGP)
1/1/2012 - 3/31/2012
48.93%
RadNet (RDNT)
1/1/2012 - 3/31/2012
46.54%
Mid-cap stocks are treated as having a market cap between $2B and $10B.